Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / helius medical technologies to present at the 2023 i mwn benzinga


HSDT - Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference | Benzinga

  • -- Presentation to educate on Portable Neuromodulation Stimulator (PoNS®) Therapy, highlighting the differentiation from other neuromodulation technologies, and the science behind its effectiveness, clinical data, safety profile --

    -- Forum brings together world experts from the core disciplines of clinical neurosciences and rehabilitation --

    NEWTOWN, Pa., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Antonella Favit-Van Pelt, M.D., Ph.D., Helius' Chief Medical Officer, will present at the Interdisciplinary Association of Neuroscience and Rehabilitation (IAFNR) Conference from September 28 to October 1, 2023. The IAFNR Conference is a four-day virtual event intended for neuroscience experts, including movement and neuromuscular disorder specialists, physical therapists, and occupational therapists.

    "It is a privilege to inform this prestigious group of clinical neuroscientists and innovators in the field of rehabilitation on the mechanistic basis and clinical outcome evidence for PoNS therapeutic benefit in gait or balance rehabilitation for people with traumatic brain injury, stroke, or multiple sclerosis," said Dr. Favit-Van Pelt. "The field of neuromodulation-based healthcare is evolving rapidly, and we believe that PoNS Therapy™ is a groundbreaking treatment for people suffering from balance or gait impairment. Our goal has always been to bring this impactful technology to as many qualifying patients as possible, and this forum is an excellent platform to create awareness and engage leading practitioners in neurorehabilitation."

    Details of the presentation are as follows:

    Presentation:
    Sustained Neuromodulation Leads to Long Term Neuroplasticity for Balance and Gait Rehabilitation
    Date:
    Saturday, September 30
    Time:
    5:00PM
    Event Registration:
    Click Here
    Webcast:
    Click Here

    About Helius Medical Technologies, Inc. 

    Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain's ability to engage physiologic compensatory mechanisms and ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: Helius Medical Technologies Inc.
    Stock Symbol: HSDT
    Market: NASDAQ

    Menu

    HSDT HSDT Quote HSDT Short HSDT News HSDT Articles HSDT Message Board
    Get HSDT Alerts

    News, Short Squeeze, Breakout and More Instantly...